Legality of cannabis

GW Pharma Sells for Billions; Psychedelic Company Following Similar Path

Retrieved on: 
Tuesday, June 29, 2021

Jazz Pharmaceuticals paying $7.2 billion for cannabis drug maker GW Pharma has investors looking at early-stage psychedelic companies.

Key Points: 
  • Jazz Pharmaceuticals paying $7.2 billion for cannabis drug maker GW Pharma has investors looking at early-stage psychedelic companies.
  • Tryp Therapeutics is one of only a handful of companies moving into Phase 2 clinical trials with a psychedelic compound.
  • GW was a true trendsetter with its Epidiolex (cannabidiol) for controlling seizures in rare forms of epilepsy.
  • A similar trend is underway with psychedelics, which are already benefiting from the path carved by cannabis drug development pioneers such as GW.

GW Pharma Sells for Billions; Psychedelic Company Following Similar Path

Retrieved on: 
Tuesday, June 29, 2021

Jazz Pharmaceuticals paying $7.2 billion for cannabis drug maker GW Pharma has investors looking at early-stage psychedelic companies.

Key Points: 
  • Jazz Pharmaceuticals paying $7.2 billion for cannabis drug maker GW Pharma has investors looking at early-stage psychedelic companies.
  • Tryp Therapeutics is one of only a handful of companies moving into Phase 2 clinical trials with a psychedelic compound.
  • GW was a true trendsetter with its Epidiolex (cannabidiol) for controlling seizures in rare forms of epilepsy.
  • A similar trend is underway with psychedelics, which are already benefiting from the path carved by cannabis drug development pioneers such as GW.

Cannabis collective expands to offer more local Québec products

Retrieved on: 
Monday, June 28, 2021

HUNTINGDON, QC, June 28, 2021 /CNW/ - The craft cannabis collective DLYS by ROSE LifeScience newly expanded to bring more locally produced options to the Qubec market.

Key Points: 
  • HUNTINGDON, QC, June 28, 2021 /CNW/ - The craft cannabis collective DLYS by ROSE LifeScience newly expanded to bring more locally produced options to the Qubec market.
  • "The micro-producers in Qubec are very talented and committed to what they are making," said ROSE LifeScience President and CEO Davide Zaffino.
  • ROSE's mission for the DLYS brand is to support local craft cannabis growers with regulated market expertise, resources and a shared commitment to Qubec values, businesses, and communities.
  • ROSE not only produces remarkable cannabis, but also offers complete marketing service to selected producers to encourage a diversified offer on the Quebec market.

New craft products from Québec help broaden cannabis collective

Retrieved on: 
Monday, June 28, 2021

Craft cannabis producer LaHoja Organique of Beauce is among the latest to launch its first product.

Key Points: 
  • Craft cannabis producer LaHoja Organique of Beauce is among the latest to launch its first product.
  • They are joined by Cultures Angers, out of Abitibi-Tmiscamingue, as the newest members of the DLYS micro-producers collective.
  • It's a great example of what can be possible in our province when it comes to craft cannabis."
  • ROSE's mission for the DLYS brand is to support local craft cannabis growers with regulated market expertise, resources and a shared commitment to Qubec values, businesses, and communities.

Sugarbud Craft Growers Corp. to Present Live at VirtualInvestorConferences.com on June 30th

Retrieved on: 
Friday, June 25, 2021

Sugarbud is an Alberta-based, consumer-driven boutique craft cannabis company - focused on the cultivation and production of exceptionally high-quality products for the most discerning of cannabis consumers.

Key Points: 
  • Sugarbud is an Alberta-based, consumer-driven boutique craft cannabis company - focused on the cultivation and production of exceptionally high-quality products for the most discerning of cannabis consumers.
  • Sugarbuds Craft Cannabis Collection strives to define the intersection of product craftsmanship, quality and value for consumers in the Canadian recreational cannabis space.
  • Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly-traded companies to meet and present directly with investors.
  • Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

Leafly Launches New Report to Score Legalized Cannabis Markets on Social Justice

Retrieved on: 
Thursday, June 24, 2021

Today, Leafly , the worlds leading cannabis marketplace and resource, released Seeds of Change: Strategies to create an equitable cannabis industry , a first-of-its-kind report that measures states efforts in making social equity a foundational part of cannabis legalization.

Key Points: 
  • Today, Leafly , the worlds leading cannabis marketplace and resource, released Seeds of Change: Strategies to create an equitable cannabis industry , a first-of-its-kind report that measures states efforts in making social equity a foundational part of cannabis legalization.
  • Building on Leaflys 2021 Cannabis Jobs Report , Seeds of Change examines the legislation of all 18 adult-use cannabis states and Washington, DC, and assigns a Leafly Equity Score based on the incorporation of eight key social justice strategies.
  • Homegrow and medical cannabis programs are the two most popular cannabis equity strategies employed by states.
  • The report also drew upon interviews with local and national experts in government policy, the cannabis business, and the field of cannabis equity.

RYAH Group Ships Devices for Use in Pilot Program with Medicann in Jersey, Channel Islands

Retrieved on: 
Wednesday, June 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication.

Key Points: 
  • Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication.
  • Jersey, Channel Islands, which is known to have one of the highest GDP per capita in the world , is a British dependency island ideally situated in the English Channel off the coast of France.
  • In 2019, the island's economy grew by 2.1% in real terms to 4.97 billion .
  • By 2024, the medicinal cannabis market within the United Kingdom is predicted to be worth nearly US$1.3 billion, servicing nearly 340,000 active patients.

Clever Leaves to Present at Upcoming Investor Conferences on June 29, 2021

Retrieved on: 
Tuesday, June 22, 2021

NEW YORK, June 22, 2021 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (Nasdaq: CLVR) (Clever Leaves or the Company), a multinational operator, or MNO, and licensed producer of pharmaceutical-grade cannabinoids, will be presenting at the following investor conferences on Tuesday, June 29, 2021:

Key Points: 
  • NEW YORK, June 22, 2021 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (Nasdaq: CLVR) (Clever Leaves or the Company), a multinational operator, or MNO, and licensed producer of pharmaceutical-grade cannabinoids, will be presenting at the following investor conferences on Tuesday, June 29, 2021:
    About Clever Leaves Holdings Inc.
  • Clever Leaves is a multinational cannabis company with an emphasis on ecologically sustainable, large-scale cultivation and pharmaceutical-grade processing as the cornerstones of its global cannabis business.
  • Clever Leaves aims to be one of the industrys leading global cannabis companies recognized for its principles, people, and performance while fostering a healthier global community.
  • Clever Leaves was granted a license in Portugal from Infarmed the Portuguese health authority which allows Clever Leaves to cultivate, import and export dry flower for medicinal and research purposes.

Clever Leaves Sends First Commercial Flower Shipment to Australia Through Commercial Partnership with IDT Australia Limited

Retrieved on: 
Monday, June 21, 2021

As part of the commercial arrangement, Clever Leaves has made its first commercial shipment of high-THC dried flower to Australia.

Key Points: 
  • As part of the commercial arrangement, Clever Leaves has made its first commercial shipment of high-THC dried flower to Australia.
  • This agreement will allow Clever Leaves to aid in the relief of the ongoing medicinal cannabis flower shortage in Australia.
  • Australia currently has limited access to quality and affordable cGMP medicinal cannabis flower products for patients in need.
  • IDT Australia Limited (ASX: IDT) is an Australian pharmaceutical manufacturing company based in Victoria, Australia.

Body and Mind Reports Record Financial Results

Retrieved on: 
Tuesday, June 22, 2021

Financial results are reported in accordance with U.S. generally accepted accounting principles ("GAAP") and all currency is in U.S. dollars.

Key Points: 
  • Financial results are reported in accordance with U.S. generally accepted accounting principles ("GAAP") and all currency is in U.S. dollars.
  • NMG Ohio production facility construction complete and State operational approvals received;
    Ownership of The Clubhouse dispensary outside Cleveland, Ohio transferred to a 100% owned Body and Mind subsidiary to allow consolidation of revenues effective September 4, 2020;
    Rebranded the dispensary as Body and Mind in September 2020;
    Commenced curbside and online express order purchasing options.
  • Both of these opportunities are expected to add revenue this fiscal year and allow expansion of Body and Mind branded offerings to new markets.
  • Please use replay number 306817 #
    View the Body and Mind video at:
    About Body and Mind Inc.
    BaM is an operations focused multi-state operator investing in high quality medical and recreational cannabis cultivation, production and retail.